Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0F5TA
|
||||
| Former ID |
DNC012034
|
||||
| Drug Name |
Ethyl-indol-1-yl-pyridin-4-yl-amine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [534087] | ||
| Formula |
C15H15N3
|
||||
| Canonical SMILES |
CCN(C1=CC=NC=C1)N2C=CC3=CC=CC=C32
|
||||
| InChI |
1S/C15H15N3/c1-2-17(14-7-10-16-11-8-14)18-12-9-13-5-3-4-6-15(13)18/h3-12H,2H2,1H3
|
||||
| InChIKey |
RBKZPZVPVZNIMS-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Alpha-2C adrenergic receptor | Target Info | Inhibitor | [534087] | |
| Alpha-2A adrenergic receptor | Target Info | Inhibitor | [534087] | ||
| Alpha-2B adrenergic receptor | Target Info | Inhibitor | [534087] | ||
| PANTHER Pathway | Alpha adrenergic receptor signaling pathway | ||||
| Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathwayP00002:Alpha adrenergic receptor signaling pathwayP00002:Alpha adrenergic receptor signaling pathway | |||||
| Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
| References | |||||